Amicus Therapeutics, Inc. (LON:0HF9)
London
· Delayed Price · Currency is GBP · Price in USD 6.57
-0.20 (-3.01%)
At close: May 2, 2025
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 1.54 billion as of May 2, 2025. Its market cap has decreased by -38.28% in one year.
Market Cap
1.54B
Enterprise Value
1.69B
Revenue
420.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.57
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 1.54B, an increase of 853.03%. That is a compound annual growth rate of 13.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 166.35B |
| GSK plc | 60.07B |
| Haleon | 33.95B |
| Smith & Nephew | 9.22B |
| ConvaTec Group | 5.31B |
| Hikma Pharmaceuticals | 4.38B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.21B |